Werth Victoria P,...,Radunovic Goran L,...,(broj koautora 18) (2025) Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary, IMMUNOTHERAPY, vol. , br. , str. - (Editorial Material; Early Access) 

Werth Victoria P,...,Radunovic Goran L,...,(broj koautora 19) (2022) Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus, NEW ENGLAND JOURNAL OF MEDICINE, vol. 387, br. 4, str. 321-331 (Article) 

Werth Victoria P,...,Radunovic Goran L,...,(broj koautora 17) (2020) BIIB059, a Humanized Monoclonal Antibody Targeting BDCA2 on Plasmacytoid Dendritic Cells (PDC), Shows Dose-Related Efficacy in the Phase 2 Lilac Study in Patients (PTS) with Active Cutaneous Lupus Erythematosus (CLE), ANNALS OF THE RHEUMATIC DISEASES, vol. 79, br. , str. 120-121 (Meeting Abstract)